Uma Sharma, PhD
Dr. Uma Sharma is a visionary drug developer recognized for her strengths in business as a national finalist and winner of the Entrepreneur of the Year award for Michigan (2020). Dr. Sharma has successfully led several global applications, including rare disease and orphan drug approvals. In collaboration with her data-focused teams, she has pioneered several new data and submission strategies, including using RWE in new drug applications.
Uma brings vision and leadership to the organization and supports community efforts as a member of the MichBio board. Her strengths, in particular, are around defining the corporate culture and team efficiencies and establishing a customer- and patient-focused global organization. Under Uma’s leadership, MMS has received multiple awards, including Best Places to Work.
Dr. Sharma earned her doctorate in pharmacology from Wayne State University and the University of Michigan.
Every colleague across the globe carries our core values into their day-to-day tasks. At the grassroots level internally, is SOUL (Sense of Urgency and Leadership) – one of our corporate values that epitomizes responsibility and hard work. SOUL continues to be appreciated by clients on every project that we support, and this is a key differentiator from other CROs.
Dr. Uma Sharma is a visionary drug developer recognized for her strengths in business as a national finalist and winner of the Entrepreneur of the Year award for Michigan (2020). Dr. Sharma has successfully led several global applications, including rare disease and orphan drug approvals. In collaboration with her data-focused teams, she has pioneered several new data and submission strategies, including using RWE in new drug applications.
Uma brings vision and leadership to the organization and supports community efforts as a member of the MichBio board. Her strengths, in particular, are around defining the corporate culture and team efficiencies and establishing a customer- and patient-focused global organization. Under Uma’s leadership, MMS has received multiple awards, including Best Places to Work.
Dr. Sharma earned her doctorate in pharmacology from Wayne State University and the University of Michigan.
Suggested For You
perspectives
February 13th, 2025
Helping European Drug Development Companies Succeed in the US Market
news
February 12th, 2025
MMS Acquires Exploristics and KerusCloud Simulation Platform to Expand Biostatistics and Data Science Capabilities as a Global Data-Focused CRO
perspectives
January 30th, 2025
Post-PDUFA VII Updates: FDA Meetings Public Workshop & Lessons Learned
perspectives
January 21st, 2025
REMS Modifications and Revisions: A Retrospective from the Past 12 Months
regulatory intelligence
January 17th, 2025
The FDA’s AI Guidance and its Seven Steps into the Future of Drug Development
regulatory intelligence
January 17th, 2025
New FDA Protocol Deviation Guidance: Planning for the Things That Don’t Go According to Plan
perspectives
January 9th, 2025
How to Create Efficiencies When Creating Simultaneous NDA and MAA Submissions for the FDA and EMA
perspectives
January 2nd, 2025
Informed Consent in Clinical Research: Understanding its Significance and Sponsor Obligations
perspectives
December 17th, 2024
Oncology Drug Development: Webinar Learnings on the Use of Expedited Pathways and Oncology Center of Excellence Programs
perspectives
December 11th, 2024
Why Emerging Biotech Companies are Increasingly Turning to Specialized Data CROs
regulatory intelligence
December 4th, 2024
FDA Issues Detailed Guidance on Development of Gene Therapy Products
news
December 4th, 2024
AI in Pharma and Innovative Leadership Were on Display at the Biennial MMS Scientific Symposium